Traws Other Operating Expenses vs Cost Of Revenue Analysis
| TRAW Stock | 5.02 0.31 5.82% |
Traws Pharma financial indicator trend analysis is much more than just breaking down Traws Pharma prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Traws Pharma is a good investment. Please check the relationship between Traws Pharma Other Operating Expenses and its Cost Of Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.
Other Operating Expenses vs Cost Of Revenue
Other Operating Expenses vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Traws Pharma Other Operating Expenses account and Cost Of Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Traws Pharma's Other Operating Expenses and Cost Of Revenue is -0.58. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Traws Pharma, assuming nothing else is changed. The correlation between historical values of Traws Pharma's Other Operating Expenses and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Traws Pharma are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Other Operating Expenses i.e., Traws Pharma's Other Operating Expenses and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | -0.58 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Traws Pharma. It is also known as Traws Pharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Traws Pharma income statement and represents the costs associated with goods and services Traws Pharma provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most indicators from Traws Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Traws Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.At this time, Traws Pharma's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 42.25 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (20.38) in 2024.
| 2020 | 2023 | 2024 (projected) | Total Revenue | 231K | 203.4K | 193.2K | Depreciation And Amortization | 13K | 16K | 15.6K |
Traws Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Traws Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.